Most Recent
A court has signed off on a $2.6 million settlement in a class action against Endeavour Energy and two other companies over the 2013 Mt Victoria bushfires that will leave class members empty-handed.
A judge has adjourned an application by law firm Slater & Gordon for a common fund order in a class action against the Commonwealth Bank and its wealth management unit, amid two landmark challenges to the courts' powers to make such orders.
Murray Goulburn and its former CEO have reached a settlement with the Australian Competition and Consumer Commission over claims the dairy producer misled farmers in three states about farmgate milk prices.
Drug maker Neurim Pharmaceuticals is battling to amend its Australian patent for the blockbuster sleeping pill Circadin over opposition from two generic pharmaceutical companies, which have accused Neurim of attempting to gain an unfair advantage by delaying the amendment bid until now.
Litigation funder Regency Funding has sought leave to intervene as a major player in one of two challenges to the courts' powers to issue common fund orders in class actions, but it might have a fight on its hands.
An attempt by Crown Resorts to block ex-employees from talking to class action lawyers about the casino giant's thwarted business in China was contrary to the public interest, a judge heard Monday.
Italian meat producer A.I.A. has lost its opposition to a trade mark application by competing salumi manufacturer Borgo, with the Registrar of Trade marks finding commonplace geometrical forms in trade marks that also feature a distinctive word are insufficient to distinguish a mark.
A software-implemented business method could be patentable if programmed into a computer with "some ingenuity", IP Australia told the Full Federal Court as a landmark appeal between rival tech companies Encompass and Infotrack wrapped up Friday.
Retail OTC derivative issuer AGM Markets has had its financial services licence canceled, after ASIC found it engaged in unconscionable conduct and failed to manage conflicts of interest.
AFT Pharmaceuticals has been ordered to pull advertisements for its painkiller Maxigesic after the Federal Court ruled in favour of rival Reckitt Benckiser, finding the ads breached Australian Consumer Law.